Analysts, along with Paul Danello, a US healthcare litigation expert, discuss status and range of outcomes of the federal MDL vs Abbott (ABT) and Reckitt (Mead Johnson) on an Analyst/Industry conference call to be held on May 8 at 10 am. Webcast Link
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ABT:
- Schwab U.S. Dividend Equity ETF (SCHD) Daily Update, 5/7/2026
- Schwab U.S. Dividend Equity ETF (SCHD) Daily Update, 5/6/2026
- Schwab U.S. Dividend Equity ETF (SCHD) Daily Update, 5/5/2026
- Schwab U.S. Dividend Equity ETF (SCHD) Daily Update, 5/4/2026
- AGNC, Lam, Abbott, BlackRock, Schlumberger: Insider Shockwave